发明专利
JP2013216661A Method and composition for treatment of bone defect with placental cell population
审中-公开
用于治疗骨缺损的方法和组合与平面细胞群体
- 专利标题： Method and composition for treatment of bone defect with placental cell population
- 专利标题（中）： 用于治疗骨缺损的方法和组合与平面细胞群体
-
申请号： JP2013110672申请日： 2013-05-27
-
公开(公告)号： JP2013216661A公开(公告)日： 2013-10-24
- 发明人: EDINGER JAMES W , HARIRI ROBERT J , WANG JIA-LUN , YE QIAN , LABAZZO KRISTEN S , PEREIRA MARIAN , ABRAMSON SASCHA DAWN
- 申请人： Anthrogenesis Corp , アントフロゲネシス コーポレーション
- 专利权人： Anthrogenesis Corp,アントフロゲネシス コーポレーション
- 当前专利权人： Anthrogenesis Corp,アントフロゲネシス コーポレーション
- 优先权： US85397106 2006-10-23; US85562906 2006-10-30; US99702207 2007-09-28
- 主分类号： A61K35/50
- IPC分类号： A61K35/50 ; A61L27/00 ; A61P35/00 ; C12N5/073 ; C12N5/0735 ; C12N5/074 ; C12N5/077
摘要：
PROBLEM TO BE SOLVED: To provide pharmaceutical compositions to treat an individual having cancers including multiple myeloma, bone cancer, neuroblastoma, osteosarcoma, Ewing's sarcoma, chondrosarcoma, chordoma, malignant fibrous histiocytoma of bone, fibrosarcoma of bone or the like.SOLUTION: A pharmaceutical composition contains an adherent placental stem cell that have been isolated from human placental tissue, the stem cell being CD105+, CD200+, CD10+, and CD34-, wherein the stem cell exists in a sufficient amount to treat a cancer.
信息查询
IPC分类:
